Every Form 4 that Abundia Global Impact Group Inc. (AGIG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow AGIG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AGIG filings page.
ABUNDIA GLOBAL IMPACT GROUP, INC. Chief Financial Officer Lucie Harwood reported a Form 4 showing a bona fide gift of 827,976 shares of Common Stock on June 26, 2026. The shares were transferred at a reported price of $0.00 per share. After this gift, Harwood directly holds 862,819 Common Stock shares.
ABUNDIA GLOBAL IMPACT GROUP, INC. director Matthew T. Henninger received a grant of stock options covering 131,870 shares of common stock. The options have an exercise price of $0.91 per share and expire on June 25, 2036. They were granted as compensation for his board service and vest quarterly over twelve months from the grant date. Following this award, he holds 131,870 stock options directly.
ABUNDIA GLOBAL IMPACT GROUP, INC. director Peter F. Longo received a grant of stock options covering 131,870 shares of common stock as compensation for his board service. The options have an exercise price of $0.91 per share and expire on June 25, 2036.
The grant vests on a quarterly schedule over twelve months from the grant date. Following this award, Longo holds stock options for 131,870 underlying shares directly, and beneficial ownership of the shares will arise only as they are issued under the company’s 2025 Equity Incentive Plan.
ABUNDIA GLOBAL IMPACT GROUP, INC. director Robert J. Bailey reported receiving a stock option grant as compensation for his board service. The award covers 131,870 shares of common stock at an exercise price of $0.91 per share and carries no upfront purchase cost.
The option vests quarterly over 12 months from the grant date and expires on June 25, 2036. Following this grant, Bailey is shown holding 131,870 derivative securities linked to common stock. The footnote states the option was granted under the issuer's 2025 Equity Incentive Plan and that beneficial ownership is disclaimed until the option is exercised and shares are issued.
Abundia Global Impact Group, Inc. director Martha Jean Crawford Heitzmann reported receiving a grant of stock options as compensation for board service. The award covers 131,870 options to buy common stock at an exercise price of $0.91 per share.
The options were granted at no cost on the grant date and expire on June 25, 2036. According to the disclosure, the options vest quarterly over twelve months from the grant date under the company’s 2025 Equity Incentive Plan, and beneficial ownership is disclaimed until shares are issued upon exercise.
ABUNDIA GLOBAL IMPACT GROUP, INC. Chief Executive Officer Edward Oliver Gillespie reported an open-market purchase of common stock. He bought 11,000 shares at $1.18 per share, increasing his direct holdings to 202,248 shares of common stock, par value $0.001 per share.
ABUNDIA GLOBAL IMPACT GROUP, INC. Chief Executive Officer Edward Oliver Gillespie made an open-market purchase of the company’s common stock. He bought 14,990 shares at a price of $1.15 per share on May 18, 2026. After this transaction, he directly owns 191,248 common shares.
ABUNDIA GLOBAL IMPACT GROUP, INC. director Robert J. Bailey reported buying additional common shares in the open market. On May 12, 2026, he completed two open-market purchases totaling 10,000 shares of common stock at prices around $1.20 per share.
The filing shows these were direct holdings of common stock and were regular open-market transactions, indicating Bailey increased his personal stake in the company.
ABUNDIA GLOBAL IMPACT GROUP, INC. director Peter F. Longo reported an open-market purchase of common stock. He bought 10,000 shares at $1.20 per share on May 12, 2026, increasing his direct holdings to 108,916 shares of common stock.
ABUNDIA GLOBAL IMPACT GROUP, INC. Chief Executive Officer Edward Oliver Gillespie purchased a total of 31,220 shares of Common Stock in the open market over three days. The reported purchase prices ranged from $1.18 to $1.22 per share.
These transactions increased his direct holdings to 176,258 Common Stock shares following the most recent purchase. All reported trades were open-market purchases and involved non-derivative Common Stock, with no derivative exercises disclosed in this filing.
Abundia Global Impact Group, Inc. director Matthew T. Henninger reported receiving a stock option grant. On February 3, 2026, he was awarded an option to purchase 33,582 shares of common stock at an exercise price of $2.68 per share.
The option was granted as compensation for his board service and will vest quarterly over twelve months from the grant date. The filing notes that he directly holds 33,582 derivative securities after this grant and disclaims beneficial ownership of the option and underlying shares until issuance under the company’s 2025 Equity Incentive Plan.
Abundia Global Impact Group, Inc. reported an insider stock grant to a board member. Director Martha Jean Crawford Heitzmann was awarded 22,388 shares of common stock on 02/03/2026 as compensation for her board services, at a stated price of $0 per share.
The award is subject to quarterly vesting over twelve months from the grant date under the company’s 2025 Equity Incentive Plan, and she disclaims beneficial ownership of the shares until they are issued. After this grant, she directly beneficially owned 50,263 shares of Abundia Global Impact Group common stock.
Abundia Global Impact Group (AGIG) disclosed that director Martha Jean Crawford Heitzmann was granted 27,875 shares of common stock on 01/21/2026. These shares were received as compensation for her service on the board of directors, with the grant priced at $0 per share. The award is subject to quarterly vesting over a twelve-month period from the grant date under the company’s 2025 Equity Incentive Plan. Beneficial ownership of the shares is disclaimed until they are issued upon vesting.
Abundia Global Impact Group, Inc. reported that Chief Executive Officer and director Edward Oliver Gillespie was granted 94,077 shares of common stock on January 21, 2026 as compensation for his services. The grant was made at a stated price of $0 per share and is subject to quarterly vesting over 12 months from the grant date under the company’s 2025 Equity Incentive Plan. Following this award, he is reported as beneficially owning 145,038 shares of common stock, and he disclaims beneficial ownership of the granted shares until they are issued under the plan.
Abundia Global Impact Group, Inc. director granted stock compensation. Director Robert J. Bailey was awarded 27,875 shares of common stock on January 21, 2026 as compensation for his service on the board. The grant is reported at a price of $0 per share, reflecting that it is an equity award rather than a cash purchase. These shares vest quarterly over twelve months from the grant date under the company’s 2025 Equity Incentive Plan, and Bailey disclaims beneficial ownership until the shares are issued upon vesting. Following this award, 95,875 common shares are reported as beneficially owned in total.
Abundia Global Impact Group, Inc. (AGIG) reported that its Chief Financial Officer, Lucie Harwood, was granted 34,843 shares of common stock on January 21, 2026. The shares were received as compensation for her services as an executive officer at a price of $0 per share and are subject to quarterly vesting over twelve months from the grant date under the company’s 2025 Equity Incentive Plan. Following this grant, she beneficially owns 34,843 shares directly, while disclaiming beneficial ownership until each tranche is issued under the plan.
Abundia Global Impact Group, Inc. director Peter F. Longo reported an award of 27,875 shares of common stock on January 21, 2026. The shares were granted as compensation for his services on the board of directors and carry a reported acquisition price of $0 per share. Following this grant, he reported beneficial ownership of 98,916 shares of common stock in total, held directly.
The awarded shares are subject to quarterly vesting over twelve months from the grant date under the company’s 2025 Equity Incentive Plan, and Longo disclaims beneficial ownership of these shares until they are issued pursuant to that plan.
Abundia Global Impact Group, Inc. director Matthew T. Henninger reported receiving a stock option grant as compensation for his board service. On January 21, 2026, he was awarded a stock option to buy 41,812 shares of common stock at $2.87 per share, expiring on January 21, 2036. The option vests quarterly over twelve months from the grant date, rather than all at once. The filing notes that he disclaims beneficial ownership of the option and the underlying common shares until they are issued under Abundia’s 2025 Equity Incentive Plan. Following this grant, 41,812 derivative securities (options) are shown as beneficially owned directly.
Abundia Global Impact Group’s chief operating officer, Joseph Gasik, was awarded 17,422 shares of common stock on January 21, 2026 as compensation for his services as an executive officer.
The shares were reported at a price of $0 per share and are subject to quarterly vesting over twelve months from the grant date under the company’s 2025 Equity Incentive Plan. Following this grant, 17,422 shares are reported as beneficially owned on a direct basis, although Gasik disclaims beneficial ownership of the shares until they are actually issued pursuant to the plan.
Abundia Global Impact Group, Inc. director Peter F. Longo filed an amended insider trading report to correct details of a prior filing. The amendment states that on June 27, 2025, the board of directors approved a grant of 40,000 shares of common stock at a price of $0 per share. The transaction date in the original report is revised to June 27, 2025.
The amendment also updates Longo’s beneficial ownership to 40,000 shares of common stock held directly. The prior total had mistakenly included 11,917.48 shares issuable upon exercise of stock options that were already reported separately as derivative securities.
Abundia Global Impact Group, Inc. director Robert J. Bailey reported a grant of 56,000 shares of the company’s common stock on June 27, 2025, received at a price of $0 per share. Following this grant, he beneficially owns 56,000 shares directly.
This filing is an amendment to a prior Form 4 filed on July 1, 2025. It corrects the transaction date to June 27, 2025, when the board approved the grant, and also corrects the total beneficial ownership, which previously and erroneously included 1,500 shares issuable upon exercise of stock options reported separately on January 17, 2025.
Abundia Global Impact Group, Inc. insider trade: the company’s Chief Executive Officer and director, Edward Gillespie, reported an open market purchase of 12,500 shares of common stock on December 23, 2025. The shares were bought at a weighted average price of $1.915 per share, with individual trade prices ranging from $1.85 to $1.96 per share. Following this transaction, Gillespie beneficially owns 50,961 shares of Abundia Global Impact Group common stock directly.
Abundia Global Impact Group, Inc. director reports open-market share purchase
Abundia Global Impact Group, Inc. director Matthew Henninger reported buying 9,500 shares of the company’s common stock on 12/19/2025. The Form 4 shows this was an open-market purchase at a price of $1.74 per share, increasing his holdings to 9,500 shares of common stock held directly.
This filing reflects an equity purchase by a board member rather than a sale, and it records his updated beneficial ownership position in Abundia Global Impact Group, Inc. following the transaction.
Abundia Global Impact Group, Inc. reported insider share purchases by Chief Executive Officer and director Edward Gillespie. On December 19, 2025, he bought 8,461 shares of common stock in open-market transactions at a weighted average price of $1.65 per share. On December 22, 2025, he bought an additional 30,000 shares in open-market trades at a weighted average price of $1.91 per share. Following these transactions, Gillespie directly beneficially owns 38,461 shares of Abundia Global Impact Group common stock.